<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05790512</url>
  </required_header>
  <id_info>
    <org_study_id>KY20232027-C-1-A</org_study_id>
    <nct_id>NCT05790512</nct_id>
  </id_info>
  <brief_title>Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection</brief_title>
  <official_title>Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital of Digestive Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital of Digestive Diseases</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the association between oral Helicobacter pylori&#xD;
      infection and gastric Helicobacter pylori infection. Patients who were tested for gastric&#xD;
      Helicobacter pylori were tested for oral Helicobacter pylori at the same time, and were&#xD;
      divided into four groups according to the test results to compare the positive rate of oral&#xD;
      Helicobacter pylori.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 22, 2022</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Positive rate of oral Helicobacter pylori</measure>
    <time_frame>7 months</time_frame>
    <description>The oral Helicobacter pylori test is performed using the Helicobacter pylori test kit</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Helicobacter Pylori</condition>
  <arm_group>
    <arm_group_label>Both gastric and oral Helicobacter pylori are negative</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Negative for Helicobacter pylori for gastric and positive for Helicobacter pylori for oral cavity</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Positive for Helicobacter pylori for gastric and negative for Helicobacter pylori for oral cavity</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Both gastric and oral Helicobacter pylori are positive</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients are from Xijing Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age between 18~70 ,both gender.&#xD;
&#xD;
          2. Initial diagnosis of stomach Helicobacter pylori infection or never had Helicobacter&#xD;
             pylori infection.&#xD;
&#xD;
          3. Have not received dental care or systemic periodontal basic treatment in the past 1&#xD;
             year.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. There is serious organ damage and complications (such as cirrhosis, uremia, etc.),&#xD;
             severe or unstable cardiopulmonary or endocrine diseases.&#xD;
&#xD;
          2. Ongoing use of antiulcer medications (including PPIs taken within 2 weeks before&#xD;
             Helicobacter pylori infection testing), antibiotics, or bismuth complexes (more than 3&#xD;
             times/week before screening).&#xD;
&#xD;
          3. Those with severe oral diseases and malignant tumors of the mouth.&#xD;
&#xD;
          4. Previously had upper gastrointestinal surgery.&#xD;
&#xD;
          5. Refusal to sign informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yongquan Shi, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Xijing Hosipital of Digestive Disease</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiaojiao Cao</last_name>
    <phone>: +86-15029258646</phone>
    <email>2119811879@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yongquan Shi, PhD</last_name>
    <phone>86-029-84771515</phone>
    <email>shiyquan@fmmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xijing Hosipital of Digestive Disease</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongquan Shi, PhD</last_name>
      <phone>86-029-84771515</phone>
      <email>shiyquan@fmmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 17, 2023</study_first_submitted>
  <study_first_submitted_qc>March 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>March 17, 2023</last_update_submitted>
  <last_update_submitted_qc>March 17, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xijing Hospital of Digestive Diseases</investigator_affiliation>
    <investigator_full_name>Yongquan Shi</investigator_full_name>
    <investigator_title>Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Oral Helicobacter Pylori</keyword>
  <keyword>Helicobacter Pylori Gastric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

